It is this? Oxford vaccine produces a “robust immune response”

Time passes and the COVID-19 pandemic reaches more and more people. Across Europe, several countries have “broken” records regarding newly infected people and this scenario is not positive for health services.

However, there appears to be a “light at the end of the tunnel”. The Oxford vaccine was able to produce a strong immune response in people over 55 years of age.

Of the dozens of vaccines in production, some are already in advanced stages, with human trials.  The vaccine that Russia has produced is very successful, according to the British scientific journal "The Lancet" but has not yet reached the "market".
The vaccine produces antibodies that can block particles and T lymphocytes
In the case of one of the first promises, the Oxford vaccine, testing stopped in September because a patient participating in the immunity study fell ill for no apparent reason.

Meanwhile, work has resumed and it seems that there is finally good news.  After testing in July, the Oxford vaccine is confirmed to produce a "robust immune response."  According to the Financial Times, the vaccine being developed by the University of Oxford can produce neutralizing antibodies.  That is, these antibodies can block foreign particles and T lymphocytes, a type of white blood cell that destroys infected cells.
Last week a 28-year-old Brazilian doctor died, who was part of the volunteer team and took the placebo.
Regarding the vaccine, there is still no concrete information.  However, it is known that Portugal expects 6.9 million vaccines.  If it works, the first shipment can arrive in early December.
Around the world, several laboratories are working intensively on a vaccine for COVID-19.  The results are not as expected yet, but there has been some progress.  In the area of ​​aviation, a great challenge may also be on the way!  According to the information, 8,000 jumbo jets will be needed to distribute the vaccine around the world.